In the previous paper1), we reported the comparative study of the enzymatic and physicochemical properties of a novel 3-lactamase produced by Bacteroides fragilis G-237 with those of a typical B. fragilis /3-lactamase produced by B.
fragilis G-242. The enzyme produced by B. fragilis G-237 showed a unique substrate profile in hydrolyzing cephalosporins including 7a-methoxycephalosporins, penicillins and carbapenems. The enzyme activity was inhibited bypchloromercuribenzoate and iodine, but not by clavulanic acid and sulbactam. The isoelectric point was 4.8, and molecular weight was estimated to be 26,000. This paper deals with the immunological properties of purified /3-lactamase from B. fragilis G-237.
Bacterial strains used in this study were: B. fragilis G-237 and G-242, Bacteroides vulgatus G-101, Bacteroides thetaiotaomicron G-282, Bacteroides ovatus G-53, Bacteroides distasonis G-50, Bacteroides uniformis G-294, Proteus vulgaris GN79712', Pseudomonas cepacia GN111643', Rtk3+/Escherichia coil TK-3 (penicillinase type I) (Richmond class III)4,5,6), Rms2l3+/E. coli W3630 (PCase type II) (Richmond class V type a)°', Rte16+/E. coli W3630 (PCase type III) (Richmond class V type b)8', Rms219+/Pseudomonas aeruginosa M1 (PCase type IV) (Richmond class V type d), Staphylococcus aureus F-186 (PCase type V), E. coli GN54829' and Enterobacter cloacae H-27.
For the preparation of crude enzymes, we followed the method described previously"). For the production of specific anti-enzyme serum, the enzymes from B. fragilis G-237 and G-242 were purified in a previously-described manner1). Other enzymes were purified by absorption and elution on a DEAE-Sephadex A-50 column or CM-Sephadex C-50 column11). Antisera against purified B. fragilis G-237 and G-242 enzymes were obtained from rabbits. One-tenth milligram of enzyme protein was dissolved in 0.5 ml of saline, emulsified with 0.5 ml of Freund complete adjuvant (Difco), and used for the first injection. An injection of 0.5 ml was given under the skin of the footpad, and the remaining dose was given in the thigh. Three weeks after the first injection, a booster injection containing 0.1 mg of enzyme protein in 0.5 nil of saline was administered intravenously. Antisera were collected 2 weeks after the last injection. The immunological identification of a 3-lactamase was demonstrated by a neutralization test using spectrophotometric method10). The enzyme solution was mixed with the antiserum at 37"C for 1 hour and then kept at 0"C for 18 hours. The mixture was centrifuged for 10 minutes at 3,000 rpm, and the remaining enzyme activity in the supernatant was assayed12).
The lactamase activity was inhibited by specific anti-enzyme serum. The standard neutralization curve was obtained by adding increasing quantities of antiserum to a fixed quantity of antigen (Fig. 1) . The enzyme activities were al- The neutralizing activities of antisera to B. fragilis G-237 and G-242 were examined by using various 13-lactamases obtained from 16 strains of clinical isolates including the above two strains.
As shown in Table 1 , antiserum to B. fragilis G-237 ,3-lactamase cross-reacted with enzyme from B. vulgatus G-101, and showed weak crossreaction with enzymes from B. fragilis G-242 and B. uniformis G-294. There was no cross-reaction with enzymes from other strains. Antiserum to B. fragilis G-242 ,3-lactamase was cross-reactive with enzymes from B. fragilis G-237, B. vulgatus G-101 and B. uniformis G-294, but not crossreactive with enzymes from other strains.
The novel 13-lactamase produced by B. fragilis G-237 is unique in terms of it's broad substrate profile, inhibitory profile and physico-chemical properties". Antisera to B. fragilis G-237 (3-lactamase and G-242 (3-lactamase cross-reacted with enzymes from B. fragilis groups, i.e., B, fragilis, B. vulgatus and B. uniformis, but did not cross-react with enzymes from B. thetaiotaomicron, B. ovatus and B. distasonis. With regard to immunological properties of (-lactamases from B. fragilis, B. vulgatus and B. thetaiotaomicron, each of the mouse antisera to those three enzymes completely neutralized not only the activities of their own enzymes, but also those of the other enzymes from the B. fragilis groups13). However, in our observations, antiserum to B. fragilis G-242 showed no cross-reaction with the enzyme from B. thetaiotaomicron. This might be due to immunological differences between the two enzymes or related to the species of animal used for the production of anti-enzyme sera.
No cross-reaction was observed between antiserum to B. fragilis and the enzymes produced by P. vulgaris and P. cepacia. Although the j3-lactamase produced by B. fragilis G-237 is very similar to oxacillin-hydrolyzing /3-lactamases (PCase type II, III) (Richmond class V type a, b) and carbenicillin-hydrolyzing p-lactamases (PCase type V) (Richmond class V type d) mediated by a transferable R pla.smid among members of the Enterobacteriaceae4, 5, 6, 14, 15) in substrate profiles and physico-chemical properties, no immunological cross-reaction were exhibited between antiserum to B. fragilis G-237 and these enzymes.
Cross-reaction between antisera prepared to specific ;3-lactamases and i3-lactamase produced by different species of bacteria are rare 4, 6, 12, 16, 17) . Immunological properties as well as enzymatic and physico-chemical properties of the enzyme from B. fragilis G-237 are different from those of the enzyme from B. fragilis G-242, and appear different from those of r3-lactamases of any class proposed by MITSUHASHI and INOUE4), RICH-MOND and SYKES5), and SYKES and MATTHEW6). where a is enzyme activity without antiserum, and b is enzyme activity with antiserum.
